tumor lysis syndromes การใช้

• Certain patient-related factors can affect the development of clinical tumor lysis syndrome.
• In 2004, Cairo and Bishop defined a classification system for tumor lysis syndrome.
• The condition, occasionally seen in people with cancer, is called tumor lysis syndrome.
• These include tumor lysis syndrome, acute phosphate nephropathy, and occasional cases of enteric hyperoxaluria.
• Chemo-sensitive tumors, such as lymphomas, carry a higher risk for the development of tumor lysis syndrome.
• Hyperphosphatemia causes acute kidney failure in tumor lysis syndrome, because of deposition of calcium phosphate crystals in the kidney parenchyma.
• Tumor Lysis Syndrome ( TLS ) is of course a major adverse event in anti-cancer treatments such as Rituxan.
• Nephrotoxicity ( kidney damage ) can be caused by tumor lysis syndrome and also due direct effects of drug clearance by the kidneys.
• :: Cytotoxic T cells usually kill their targets by induction of apoptosis ( programmed cell death ), which may result in tumor lysis syndrome.
• Tumors with a high cell turnover rate, rapid growth rate, and high tumor bulk tend to be more associated with the development of tumor lysis syndrome.
• This paper reports a case of modified T cell treatment for chronic lymphoid leukemia where delayed tumor lysis syndrome occurred .-- talk ) 08 : 48, 4 September 2012 ( UTC)
• Serious side effects included severe myelosuppression ( suppressed activity of bone marrow, which is involved in formation of various blood cells [ found in 98 % of patients ] ), disorder of the respiratory system, tumor lysis syndrome, Type III hypersensitivity, venous occlusion, and death.